Show simple item record

dc.contributor.authorO'Ketch, Marvin
dc.contributor.authorWilliams, Spencer
dc.contributor.authorLarson, Cameron
dc.contributor.authorUhrlaub, Jennifer L
dc.contributor.authorWong, Rachel
dc.contributor.authorHall, Brenna
dc.contributor.authorDeshpande, Neha R
dc.contributor.authorSchenten, Dominik
dc.date.accessioned2021-04-17T02:06:47Z
dc.date.available2021-04-17T02:06:47Z
dc.date.issued2020-10-26
dc.identifier.citationO’Ketch, M., Williams, S., Larson, C., Uhrlaub, J. L., Wong, R., Hall, B., ... & Schenten, D. (2020). MAVS regulates the quality of the antibody response to West-Nile Virus. PLoS Pathogens, 16(10), e1009009.en_US
dc.identifier.issn1553-7366
dc.identifier.pmid33104760
dc.identifier.doi10.1371/journal.ppat.1009009
dc.identifier.urihttp://hdl.handle.net/10150/657814
dc.description.abstractA key difference that distinguishes viral infections from protein immunizations is the recognition of viral nucleic acids by cytosolic pattern recognition receptors (PRRs). Insights into the functions of cytosolic PRRs such as the RNA-sensing Rig-I-like receptors (RLRs) in the instruction of adaptive immunity are therefore critical to understand protective immunity to infections. West Nile virus (WNV) infection of mice deficent of RLR-signaling adaptor MAVS results in a defective adaptive immune response. While this finding suggests a role for RLRs in the instruction of adaptive immunity to WNV, it is difficult to interpret due to the high WNV viremia, associated exessive antigen loads, and pathology in the absence of a MAVS-dependent innate immune response. To overcome these limitations, we have infected MAVS-deficient (MAVS(KO)) mice with a single-round-of-infection mutant of West Nile virus. We show that MAVS(KO) mice failed to produce an effective neutralizing antibody response to WNV despite normal antibody titers against the viral WNV-E protein. This defect occurred independently of antigen loads or overt pathology. The specificity of the antibody response in infected MAVS(KO) mice remained unchanged and was still dominated by antibodies that bound the neutralizing lateral ridge (LR) epitope in the DIII domain of WNV-E. Instead, MAVS(KO) mice produced IgM antibodies, the dominant isotype controlling primary WNV infection, with lower affinity for the DIII domain. Our findings suggest that RLR-dependent signals are important for the quality of the humoral immune response to WNV. Author summary A key difference that distinguishes viral infection from protein immunization is the detection of viral nucleic acids by cytosolic pattern recognition receptors (PRRs) including the RNA-sensing Rig-I-like receptors (RLRs). Insights into the specific function of RLRs are therefore critical for the understanding of protective immunity to infections. Here, we have infected mice deficient in RLR signaling with an attenuated mutant of West Nile virus (WNV). We show that the anti-viral antibody response of these mice failed to neutralize the virus effectively because the majority of WNV-specific antibodies poorly bound the virus. Our findings suggest that the detection of WNV by RLRs regulates the quality of the anti-viral antibody response.en_US
dc.language.isoenen_US
dc.publisherPUBLIC LIBRARY SCIENCEen_US
dc.rights© 2020 O’Ketch et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleMAVS regulates the quality of the antibody response to West-Nile Virusen_US
dc.typeArticleen_US
dc.identifier.eissn1553-7374
dc.contributor.departmentUniv Arizona, Dept Immunobiolen_US
dc.identifier.journalPLOS PATHOGENSen_US
dc.description.noteOpen access journalen_US
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en_US
dc.eprint.versionFinal published versionen_US
dc.source.journaltitlePLoS pathogens
dc.source.volume16
dc.source.issue10
dc.source.beginpagee1009009
dc.source.endpage
refterms.dateFOA2021-04-17T02:06:48Z
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States


Files in this item

Thumbnail
Name:
ppat.1009009.pdf
Size:
2.419Mb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

© 2020 O’Ketch et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.
Except where otherwise noted, this item's license is described as © 2020 O’Ketch et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.